Clinical trials
Nephrolithiasis trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
60 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 4 |
| 2006 | 3 |
| 2009 | 4 |
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 6 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 7 |
| 2025 | 7 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
| Recruiting | 12 |
| Withdrawn | 5 |
| Terminated | 4 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Icahn School of Medicine at Mount Sinai | 4 |
| University of Alabama at Birmingham | 4 |
| VA New York Harbor Healthcare System | 4 |
| Indiana Kidney Stone Institute | 3 |
| University of Kansas Medical Center | 3 |
| University of Wisconsin, Madison | 3 |
| Washington University School of Medicine | 3 |
| Calyxo, Inc. | 2 |
| MaineHealth | 2 |
| Northwestern University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nephrolithiasis | 60 |
| Kidney Calculi | 36 |
| Urolithiasis | 20 |
| Hypercalciuria | 4 |
| Ureterolithiasis | 4 |
| Hyperoxaluria | 3 |
| Kidney Diseases | 3 |
| Ureteral Calculi | 3 |
| Obesity | 2 |
| Urinary Tract Infections | 2 |
Trials
Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.